资讯
Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.
The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果